The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Verastem, Inc(NASDAQ:VSTM) 
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that ...
Website: http://www.verastem.com
Founded: 2010
Full Time Employees: 135
Sector: Healthcare
Industry: Biotechnology
Verastem Days Payable Outstanding ttm (DPO)
Verastem Days Receivable Outstanding ttm (DSO)
Verastem Days Inventory Outstanding ttm (DIO)
Verastem Op Cashflow Per Share ttm
Verastem Free Cashflow Per Share ttm
Verastem Cash Per Share ttm
Verastem P/S ratio ttm
Verastem (GAAP) P/E ratio ttm
Verastem P/B ratio ttm
No extra charts and metrics for this ticker.